559 related articles for article (PubMed ID: 33689402)
1. Effect of Care Rehabilitation on Medical Expenses, Care Costs, and Total Costs of Elderly Individuals with Parkinson's Disease.
Liu N; Babazono A; Kim SA; Li Y
Popul Health Manag; 2021 Dec; 24(6):738-747. PubMed ID: 33689402
[TBL] [Abstract][Full Text] [Related]
2. Impact of long-term care insurance on medical costs and utilization by patients with Parkinson's disease.
Kim SH; Park EC; Jang SY
Soc Sci Med; 2023 Jan; 317():115563. PubMed ID: 36455406
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
4. Effects of physician visit frequency for Parkinson's disease treatment on mortality, hospitalization, and costs: a retrospective cohort study.
Fujita T; Babazono A; Kim SA; Jamal A; Li Y
BMC Geriatr; 2021 Dec; 21(1):707. PubMed ID: 34911495
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.
Weir S; Samnaliev M; Kuo TC; Tierney TS; Walleser Autiero S; Taylor RS; Schrag A
Mov Disord; 2018 Jul; 33(6):974-981. PubMed ID: 29603405
[TBL] [Abstract][Full Text] [Related]
6. The current and projected economic burden of Parkinson's disease in the United States.
Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
[TBL] [Abstract][Full Text] [Related]
7. Association between care rehabilitation and the risk of fracture hospitalization in people with Parkinson's disease.
Liu N; Babazono A; Ishihara R; Li Y; Jamal A; Kim SA; Matsuda S
Geriatr Gerontol Int; 2022 Aug; 22(8):628-634. PubMed ID: 35777740
[TBL] [Abstract][Full Text] [Related]
8. Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population.
Dahodwala N; Li P; Jahnke J; Ladage VP; Pettit AR; Kandukuri PL; Bao Y; Zamudio J; Jalundhwala YJ; Doshi JA
Mov Disord; 2021 Jan; 36(1):133-142. PubMed ID: 33031604
[TBL] [Abstract][Full Text] [Related]
9. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.
Dodel RC; Singer M; Köhne-Volland R; Szucs T; Rathay B; Scholz E; Oertel WH
Pharmacoeconomics; 1998 Sep; 14(3):299-312. PubMed ID: 10186468
[TBL] [Abstract][Full Text] [Related]
10. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
[TBL] [Abstract][Full Text] [Related]
11. Burden of illness in Parkinson's disease.
Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany.
Winter Y; Balzer-Geldsetzer M; Spottke A; Reese JP; Baum E; Klotsche J; Rieke J; Simonow A; Eggert K; Oertel WH; Dodel R
Eur J Neurol; 2010 Sep; 17(9):1156-1163. PubMed ID: 20345926
[TBL] [Abstract][Full Text] [Related]
13. A review of the health-related quality of life and economic impact of Parkinson's disease.
Dowding CH; Shenton CL; Salek SS
Drugs Aging; 2006; 23(9):693-721. PubMed ID: 17020395
[TBL] [Abstract][Full Text] [Related]
14. Does long-term care insurance reduce the burden of medical costs? A retrospective elderly cohort study.
Choi JW; Park EC; Lee SG; Park S; Ryu HG; Kim TH
Geriatr Gerontol Int; 2018 Dec; 18(12):1641-1646. PubMed ID: 30311345
[TBL] [Abstract][Full Text] [Related]
15. Cost of illness and its predictors for Parkinson's disease in Germany.
Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R
Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
Yamabe K; Liebert R; Flores N; Pashos C
J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
[TBL] [Abstract][Full Text] [Related]
17. [Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].
Dodel RC; Singer M; Köhne-Volland R; Selzer R; Scholz W; Rathay B; Oertel WH
Nervenarzt; 1997 Dec; 68(12):978-84. PubMed ID: 9465341
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial.
Radder DLM; Lennaerts HH; Vermeulen H; van Asseldonk T; Delnooz CCS; Hagen RH; Munneke M; Bloem BR; de Vries NM
Trials; 2020 Jan; 21(1):88. PubMed ID: 31941538
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.
Suh DC; Pahwa R; Mallya U
J Neurol Sci; 2012 Aug; 319(1-2):24-31. PubMed ID: 22664154
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Healthcare Utilization and Costs in Parkinson's Disease: Pre-Diagnosis to 9 Years After.
Soh EML; Neo S; Saffari SE; Wong ASY; Ganesan G; Li W; Ng HL; Xu Z; Tay KY; Au WL; Tan KB; Tan LCS
J Parkinsons Dis; 2022; 12(3):957-966. PubMed ID: 34974439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
